The cannabinoid δ9-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells

Cited in:

CrossRef

This article has been cited by:

1. 1
   Gabriella Aviello, Barbara Romano, Francesca Borrelli, Raffaele Capasso, Laura Gallo, Fabiana Piscitelli, Vincenzo Di Marzo, Angelo A. Izzo, Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer, Journal of Molecular Medicine, 2012,

   CrossRef

2. 2
   Haitao Wang, Qishan Zhang, Lang Zhang, Peter J. Little, Xiaochun Xie, Qian Meng, Yannan Ren, Lihua Zhou, Guoquan Gao, Remi Quirion, Wenhua Zheng, Insulin-like growth factor-1 induces the phosphorylation of PRAS40 via the PI3K/Akt signaling pathway in PC12 cells, Neuroscience Letters, 2012, 516, 1, 105

   CrossRef

3. 3
   Maria C. Proto, Patrizia Gazzerro, Luciano Di Croce, Antonietta Santoro, Anna M. Malfitano, Simona Pisanti, Chiara Laezza, Maurizio Bifulco, Interaction of endocannabinoid system and steroid Hormones in the control of colon cancer cell growth, Journal of Cellular Physiology, 2012, 227, 1

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(420K)
   • References
4. 4
   Jae Myung Park, Xiang-Shu Xian, Myung-Gyu Choi, Hyeyeon Park, Yu Kyung Cho, In Seok Lee, Sang Woo Kim, In-Sik Chung, Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells, Journal of Cellular Biochemistry, 2011, 112, 4

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(2350K)
   • References
5. 5
   Daniel J. Hermanson, Lawrence J. Marnett, Cannabinoids, endocannabinoids, and cancer, Cancer and Metastasis Reviews, 2011, 30, 3-4, 599

   CrossRef

6. 6
   Angelo A. Izzo, Keith A. Sharkey, Cannabinoids and the gut: New developments and emerging concepts, Pharmacology & Therapeutics, 2010, 126, 1, 21

   CrossRef

7. 7
   Xiang-Shu Xian, Hyeyeon Park, Yu Kyung Cho, In Seok Lee, Sang Woo Kim, Myung-Gyu Choi, In-Sik Chung, Ki-Hwan Han, Jae Myung Park, Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells, Journal of Cellular Biochemistry, 2010, 110, 2

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(500K)
   • References
8. 8
   Rudolf Schicho, Martin Storr, Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies, Expert Review of Clinical Pharmacology, 2010, 3, 2, 193

   CrossRef

9. 9
   Mauro Maccarrone, Valeria Gasperi, Maria Valeria Catani, Thi Ai Diep, Enrico Dainese, Harald S. Hansen, Luciana Avigliano, The Endocannabinoid System and Its Relevance for Nutrition, Annual Review of Nutrition, 2010, 30, 1, 423

   CrossRef

10. 10
    A Greenhough, C A Wallam, D J Hicks, M Moorghen, A C Williams, C Paraskeva, The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE2 signalling in colorectal adenoma cells, Oncogene, 2010, 29, 23, 3398

    CrossRef

11. 11
    Susanne Oesch, Jürg Gertsch, Cannabinoid receptor ligands as potential anticancer agents — high hopes for new therapies?, Journal of Pharmacy and Pharmacology, 2009, 61, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(413K)
    • References
12. 12
    A. E. Moore, A. Greenhough, H. R. Roberts, D. J. Hicks, H. A. Patsos, A. C. Williams, C. Paraskeva, HGF/Met signalling promotes PGE2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells, Carcinogenesis, 2009, 30, 10, 1796

    CrossRef

13. 13
    Sumner Burstein, Rebecca Salmonsen, Acylamido analogs of endocannabinoids selectively inhibit cancer cell proliferation, Bioorganic & Medicinal Chemistry, 2008, 16, 22, 9644

    CrossRef

14. 14
    K L Wright, M Duncan, K A Sharkey, Cannabinoid CB₂ receptors in the gastrointestinal tract: a regulatory system in states of inflammation, British Journal of Pharmacology, 2008, 153, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(226K)
    • References
15. 15
    Sofia B. Gustafsson, Theres Lindgren, Maria Jonsson, Stig O. P. Jacobsson, Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil, Cancer Chemotherapy and Pharmacology, 2008, 63, 4, 691

    CrossRef

16. 16
    Wai M. Liu, Katherine A. Scott, Jonathan Shamash, Simon Joel, Thomas B. Powles, Enhancing thein vitrocytotoxic activity of Δ9-tetrahydrocannabinol in leukemic cells through a combinatorial approach, Leukemia & Lymphoma, 2008, 49, 9, 1800

    CrossRef

17. 17
    Karen L. Wright, Duncan A.F. Robertson, Mary P. Moyer, Stephen G. Ward, Long term cannabinoid receptor (CB1) blockade in obesity: Implications for the development of colorectal cancer, International Journal of Cancer, 2008, 122, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(66K)
18. 18
    Pedro Gonçalves, João Ricardo Araújo, Maria João Pinho, Fátima Martel, Modulation of butyrate transport in Caco-2 cells, Naunyn-Schmiedeberg's Archives of Pharmacology, 2008, 379, 4, 325

    CrossRef

19. 19
    Barbara Bosier, Didier M. Lambert, Emmanuel Hermans, Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells, FEBS Letters, 2008, 582, 28, 3861

    CrossRef

20. 20
    Jenny Flygare, Birgitta Sander, The endocannabinoid system in cancer—Potential therapeutic target?, Seminars in Cancer Biology, 2008, 18, 3, 176

    CrossRef